Vaccination of melanoma patients with peptide-or tumorlysate-pulsed dendritic cells
… by culturing bone marrow or peripheral blood cells in the … stem cell factor, and FLT3 ligand"".
Here we report for the first time on the vaccination of 16 melanoma patients with peptides or …
Here we report for the first time on the vaccination of 16 melanoma patients with peptides or …
Phase I dendritic cell p53 peptide vaccine for head and neck cancer
PJ Schuler, M Harasymczuk, C Visus, A DeLeo… - Clinical Cancer …, 2014 - AACR
… of adjuvant p53 peptide-loaded dendritic cell (DC) based adjuvant vaccination for patients
with … vaccine for these patients. With the recent US Food and Drug Administration approval of …
with … vaccine for these patients. With the recent US Food and Drug Administration approval of …
Peptide and dendritic cell vaccines
CL Slingluff Jr, VH Engelhard, S Ferrone - Clinical cancer research, 2006 - AACR
… ; some have used peptide(s) pulsed on dendritic cells. Many of … cell responses can be
generated by vaccination with peptide … that peptide vaccines do not work, that cancer vaccines in …
generated by vaccination with peptide … that peptide vaccines do not work, that cancer vaccines in …
The use of dendritic cells for peptide-based vaccination in cancer immunotherapy
ML Salem - Cancer vaccines: methods and protocols, 2014 - Springer
… T-cell responses but with limited effects even if the peptide is co-… to cancer-induced dysfunction
in dendritic cells (DC), which … Therefore, DC-based peptide delivery of tumor antigen is …
in dendritic cells (DC), which … Therefore, DC-based peptide delivery of tumor antigen is …
Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells
REM Toes, EIH van der Voort… - The Journal of …, 1998 - journals.aai.org
… a peptide that readily induces specific CTL tolerance when administered sc in adjuvants. In
this study, we show that peptide-loaded dendritic cells (… of synthetic peptide delivery cause …
this study, we show that peptide-loaded dendritic cells (… of synthetic peptide delivery cause …
Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope–based peptide vaccine in protection against a human papillomavirus type 16–induced tumor
MA Ossevoort, MCW Feltkamp… - Journal of …, 1995 - journals.lww.com
… tumor cells (C3 cells… dendritic cells (DC) that efficiently induce primary peptide-specific CTL
responses in vitro, as physiological carriers for the HPV 16 E7(49–57) peptide-based vaccine…
responses in vitro, as physiological carriers for the HPV 16 E7(49–57) peptide-based vaccine…
In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity
B Ludewig, F Barchiesi, M Pericin, RM Zinkernagel… - Vaccine, 2000 - Elsevier
… Next, we sought to further optimise the liposomal peptide vaccine and to test the ability of
the vaccine to induce protective antiviral immunity. Oligonucleotides containing unmethylated …
the vaccine to induce protective antiviral immunity. Oligonucleotides containing unmethylated …
[HTML][HTML] Use of cell-penetrating peptides in dendritic cell-based vaccination
… is highly synergistic with the cellular characteristics of the dendritic cells (DCs), … vaccine with
peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells…
peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells…
[HTML][HTML] Adjuvant-free peptide vaccine targeting Clec9a on dendritic cells can induce robust antitumor immune response through Syk/IL-21 axis
S Gou, S Wang, W Liu, G Chen, D Zhang, J Du… - Theranostics, 2021 - ncbi.nlm.nih.gov
… CBP-12 vaccine. Finally, we assessed the effects of the CBP-12 conjugated peptide vaccine
combined with radiotherapy. Results: Here, we developed CBP-12 as a vaccine carrier that …
combined with radiotherapy. Results: Here, we developed CBP-12 as a vaccine carrier that …
Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy
… peptide-based subunit vaccine formulations for the direct delivery of tumor antigen peptides
(Aps) to dendritic cells … , so their role as potential vaccine targets has been largely overlooked…
(Aps) to dendritic cells … , so their role as potential vaccine targets has been largely overlooked…
相关搜索
- liposomal peptide vaccine dendritic cells
- cancer vaccination dendritic cells
- patients with metastatic melanoma dendritic cells
- autologous dendritic cells
- peptide vaccination tumor outgrowth
- peptide vaccine clec9a on dendritic cells
- dendritic cell based vaccines
- clinical responses dendritic cell vaccination
- dendritic cells in vaccination therapies
- conventional chemotherapy dendritic cell vaccination
- mode of delivery dendritic cell vaccination
- antigen receptor dendritic cell vaccine
- p53 peptide pulsed dendritic cells
- cell penetrating peptide vaccine development
- peptide carrier dendritic cells
- dendritic cells in the treatment